US 9771403
Methods and compositions for treating hemophilia
granted A61KA61K48/00A61P
Quick answer
US patent 9771403 (Methods and compositions for treating hemophilia) held by Sangamo Therapeutics, Inc. expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K48/00, A61P, A61P3/00, A61P43/00